Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Gültekin, Süleymanlar"'
Publikováno v:
Turkish Journal of Nephrology, Vol 31, Iss 4, Pp 279-283 (2022)
Externí odkaz:
https://doaj.org/article/6aac75f714fd42e8a1660729cbdc2ff5
Publikováno v:
Turkish Journal of Nephrology, Vol 31, Iss 2, Pp 103-109 (2022)
Externí odkaz:
https://doaj.org/article/abbc5580cc8d4877a1a2b2bb30c4e957
Autor:
Mehmet Birhan Yılmaz, Mustafa Kılıçkap, Adnan Abacı, Cem Barçın, Fahri Bayram, Doruk Karaaslan, Hüseyin Göksülük, Meral Kayıkçıoğlu, Necla Özer, Gültekin Süleymanlar, Mahmut Şahin, Lale Tokgözoğlu, İlhan Satman
Publikováno v:
Türk Kardiyoloji Derneği Arşivi, Vol 46, Iss 7, Pp 546-555 (2018)
Objective: Diabetes mellitus (DM) is a serious public health problem. Despite various epidemiological studies reporting prevalence of DM in Turkey, there is no meta-analysis or systematic review evaluating these studies as a whole and assessing tempo
Externí odkaz:
https://doaj.org/article/c025113f5a8d4db99f7a0ec672951455
Autor:
Cuma Bülent Gül, Mehmet Küçük, Savaş Öztürk, Erol Demir, Necmi Eren, Abdullah Şumnu, Nurhan Seyahi, Mustafa Güllülü, Fatih Dede, Ülver Derici, Yener Koç, Garip Şahin, Oktay Oymak, Gülizar Manga Sahin, Erhan Tatar, Belda Dursun, Hamad Dheir, Süheyla Apaydın, Gültekin Süleymanlar, Sena Ulu, Orçun Altınören, Sim Kutlay, Meral Meşe, İdris Şahin, Sedat Üstündağ, Kültigin Türkmen, Mehmet Emin Yılmaz, Rümeyza Turan Kazancıoğlu, Özcan Uzun, Ferhan Candan, Zeki Aydın, Deren Oygar, Nimet Aktaş, Yunus Erdem, Saime Paydaş, Dilek Taymez, Başak Can, Ahmet Kıykım, Leyla Koç, Siren Sezer, Murat Duranay, Simge Bardak, Lütfullah Altıntepe, Burcu Kaya, Alper Azak, Sebahat Alışır Ecder, Caner Çavdar, Nedim Yılmaz Selçuk
Publikováno v:
International urology and nephrology. 54(9)
Background: Although several renal biopsy registry reports have been published worldwide, there are no data on primary glomerular disease trends in Turkey. Methods: Three thousand eight-hundred fifty-eight native kidney biopsy records were assessed i
Autor:
Asli Baykal, Bilge Karatoy Erdem, Gültekin Süleymanlar, Filiz Ozcan, Sadıka Halide Akbaş, Vural Taner Yilmaz
Publikováno v:
International Journal of Medical Biochemistry. 1
Autor:
Tevfik, Ecder, Cengiz, Utas, Kenan, Ates, Brian, Bieber, Bruce M, Robinson, Ronald L, Pisoni, Gültekin, Süleymanlar
Publikováno v:
Hemodialysis international. International Symposium on Home Hemodialysis. 21(3)
Turkey has one of the largest treated end-stage renal disease (ESRD) patient populations in Europe (N = 66,711). In 2013, the international Dialysis Outcomes and Practice Patterns Study (DOPPS), a prospective study of hemodialysis (HD) practices and
Autor:
Caglar Ruhi, Huseyin Kocak, Gültekin Süleymanlar, Dilek Colak, Alihan Gurkan, G Yakupoglu, Vural Taner Yilmaz, Ayhan Dinçkan, Inci Suleymanlar, F. Fevzi Ersoy
Publikováno v:
The Turkish Journal of Gastroenterology. 22:165-170
BACKGROUND/AIMS: The aim of this study was to determine the effect of hepatitis C virus infection on patient and graft survival and liver function in renal transplant patients. METHODS: 1811 renal transplant patients were included in this study. One
Autor:
Gültekin, Süleymanlar, Kamil, Serdengeçti, Mehmet R, Altiparmak, Kitty, Jager, Nurhan, Seyahi, Ekrem, Erek, Murat, Yorum Consultancy Ltd
Publikováno v:
American journal of kidney diseases, 57(3), 456-465. W.B. Saunders Ltd
Background National renal registry studies providing data for incidence, prevalence, and characteristics of end-stage renal disease and renal replacement therapy (RRT) serve as a basis to determine national strategies for the prevention and treatment
Autor:
Sebahat Ozdem, Gültekin Süleymanlar, Nusret Yilmaz, Hasan Ali Altunbas, Atakan Yanikoglu, Güven Barış Cansu, Aytül Belgi Yıldırım
Publikováno v:
Endocrine Abstracts.
Autor:
Çağlar, Ruhi, İnci, Süleymanlar, Hüseyin, Koçak, Ayhan, Dinçkan, Fevzi, Ersoy, Gültekin, Süleymanlar
Publikováno v:
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 13(1)
Chronic hepatitis B virus infection remains a clinical problem for HBsAg (+) kidney transplant recipients. Lamivudine is the approved treatment; however, there are contrary views about optimal initiation. In case of resistance, novel nucleoside analo